NU Skin Enterprises Inc. Class A (NUS)

CONSUMER STAPLES: PERSONAL PRODUCTS
SIC: WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

75 WEST CENTER ST PROVO, UT 84601

NU Skin Enterprises is a direct selling company with operations in 52 markets worldwide. Co. develops and distributes personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively. Co.'s Nu Skin product line by category includes: core systems; targeted treatments; total care; cosmetic; and Epoch. Co.'s Pharmanex product line by category includes: nutritional; anti-aging, solutions; weight management; and Vitameal. In addition, Co. provides a limited number of other products and services, including household products and digital content storage. Co. sells its products to a network of independent distributors, except its operations in Mainland China.

Data as of 2020-08-01
Market Cap2.328 Billion Shares Outstanding51.899 Million Avg 30-day Volume749.496 Thousand
P/E Ratio16.7 Dividend Yield3.344 EPS2.69
Price/Sales1.376 Price cash flow ratio9.8 Price free cash flow ratio42.8
Book Value15.42 Price to Tangible Book4.43 Alpha0.0
Short Interest Ratio2.31 % Short Interest to Float3.9 R-squared0.200574
BETA1.24706 52-week High/Low48.61 / 12.305 Stddev0.119803
View SEC Filings from NUS instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 192 51 (3.34%)
Aggregate 13F shares on 03/31/2020: 37.857 Million 19.101 Million
Aggregate 13F shares on 12/31/2019: 41.207 Million 20.436 Million
Percent change: -8.13% -6.53%
Funds creating new positions: 28 13
Funds Adding to an existing position: 82 18
Funds closing out their position: 50 23
Funds reducing their position: 46 16
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NUS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NUS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WOODBURY EDWINA D

  • Director
13,445 2020-06-10 5

CHANG JOSEPH Y CHIEF SCIENTIFIC OFFICER

  • Officer
102,882 2020-06-05 4

WOOD RITCH N CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
199,170 2020-06-03 4

DORNY D MATTHEW GENERAL COUNSEL

  • Officer
45,673 2020-06-03 3

THOMAS PISANO R.

  • Director
50,968 2020-06-03 1

CAMPBELL DANIEL W

  • Director
75,802 2020-06-03 1

LIPMAN ANDREW D

  • Director
72,712 2020-06-03 1

NAPIERSKI RYAN S PRESIDENT

  • Officer
91,500 2020-06-03 4

LAWRENCE MARK H CHIEF FINANCIAL OFFICER

  • Officer
52,519 2020-06-03 3

SHEN ZHEQING

  • Director
11,987 2020-06-03 1

NATHANSON LAURA

  • Director
6,490 2020-06-03 1

THOMAS JAMES D CHIEF ACCOUNTING OFFICER

  • Officer
7,111 2020-06-03 2

CHARD DANIEL R CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
138,981 2020-02-19 0

OFFEN NEIL H

  • Director
10,083 2019-05-21 0

ANDERSEN NEVIN N

  • Director
34,045 2019-05-21 0

LUND STEVEN EXEC. CHAIRMAN OF THE BOARD

  • Officer
  • Director
285,218 2018-12-31 0

PING AN ZQ CHINA GROWTH OPPORTUNITY LTD

SHEN ZHEQING

  • Director
0 2018-03-07 1

SHEN ZHEQUING

  • Director
3,456 2017-05-11 0

HUNT M TRUMAN PRESIDENT & CEO

  • Officer
  • Director
0 2017-02-27 0

SCHWERDT SCOTT E PRESIDENT, AMERICAS REGION

  • Officer
0 2015-12-18 0

NEGRON PATRICIA

  • Director
No longer subject to file 2015-05-13 0

GARN EJ JAKE

  • Director
No longer subject to file 2013-02-21 0

TILLOTSON SANDRA

  • Director
3,160,845 2012-05-04 0

USSERY DAVID D.

  • Director
13,222 2012-02-09 0

RONEY BLAKE CHAIRMAN OF THE BOARD

  • Officer
  • Director
  • 10% Owner
3,716,458 2011-04-12 0

PAHWA ASHOK CHIEF MARKETING OFFICER

  • Officer
3,322 2009-08-28 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

WOODBURY EDWINA D - Director

2020-06-10 A 14 $38.49 a 13,445 13,445.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments